Navigation Links
Immune Deficiency Foundation Launches Free Accredited Course for Nurses About Primary Immunodeficiency and Immunoglobulin Therapy

tion: Primary Immunodeficiencies, Combined T-cell and/or B-cell Immune Defects
  • Kristin Epland, MSN, FNP-C, Midwest Immunology Clinic, Plymouth, MN
    Presentation: Intravenous Immunoglobulin Therapy (IVIG)
  • M. Elizabeth Younger, CRNP, PhD, Johns Hopkins University, Baltimore, MD
    Presentation: Subcutaneous Immunoglobulin Therapy (SCIG)

  • Sponsored by an unrestricted educational grant from CSL Behring, this free online course will help any nurse who is involved with administration and management of immunoglobulin therapy or primary immunodeficiency diseases where immunoglobulin is used.

    "Each nurse will walk away from this course with a greater knowledge of primary immunodeficiency and their role treating patients," said Boyle, who founded IDF 30 years ago.  "IDF wants to improve health outcomes and increase optimal treatment for our patients.  We believe this course will help accomplish this."  


    To register for the course, interested nurses can go directly to the course site at :  In the login prompt, you will be able to register on the site, and then move on to take the course.

    About IDF

    The Immune Deficiency Foundation (IDF) was founded in 1980.

    On behalf of those with primary immunodeficiency diseases, IDF provides educational programs and materials that offer medical information, guidance about health insurance issues, important life management and patient care resources, and support for patients and family members.  IDF supports advocacy to promote healthcare legislation and policies that positively affect the primary immunodeficie

    SOURCE Immune Deficiency Foundation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related biology technology :

    1. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
    2. Peptimmune Presentation at Upcoming World Congress on Treatment and Research in Multiple Sclerosis
    3. EUPROBIO 2008 Presentation to Highlight Latest Immune Research
    4. MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease
    5. MedImmune Expands R&D Capacity with New Research Facility in Cambridge, U.K.
    6. MedImmune Licenses Reverse Genetics Technology to Hungarys Omninvest for Use in Influenza Vaccine Development and Production
    7. MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology
    8. Peptimmune Presentations at Upcoming Events
    9. Protein-printing technique gives snapshots of immune system defense
    10. Visualizing asthma-causing immune cells at work
    11. AutoImmune Inc. Reports 2008 Third Quarter Financial Results
    Post Your Comments:
    (Date:8/21/2014)... (PRWEB) August 21, 2014 DNA vaccine ... progress in its development of JRC-LAMP-vax, an innovative and ... pollen. Phase IC studies began this month in Hawaii, ... hay fever. , The Japanese red cedar releases pollen ... in Japan. Mountain Cedar pollen wreaks similar havoc in ...
    (Date:8/21/2014)... research team including DESY scientists has observed tiny quantum ... reports in the journal Science that the ... the nanodroplets. It is the first time that the ... samples of what is known as superfluid helium, have ... best expectations," says Andrey Vilesov of the University of ...
    (Date:8/21/2014)... 21, 2014 ... announced the addition of the  "Global Hormone ... offering.       (Logo: ,Hormone ... is a means of replacing hormones that ... body. This type of therapy is usually ...
    (Date:8/21/2014)... COLD SPRING, N.Y. , Aug. 21, 2014 ... today the launch of their Nutraceutical "TELO-20 for ... first and only Telomere-lengthening supplement in the world ... the ends of every chromosome in the body. ... the world,s leading experts in Telomere Science and ...
    Breaking Biology Technology:Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S. 2Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S. 3Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S. 4Scientists observe quantum vortices in cold helium droplets 2Global Hormone Replacement Therapy Market 2014-2018: Key Vendors are Actavis, Bayer, Merck & Co, Novartis and Novo Nordisk 2Telomere Biosciences Announces: TELO-20 for Dogs, the World's First Telomere-Lengthening Supplement for Dogs, to Promote Healthy Aging and Longevity 2Telomere Biosciences Announces: TELO-20 for Dogs, the World's First Telomere-Lengthening Supplement for Dogs, to Promote Healthy Aging and Longevity 3
    ... Wis. - Recently, as I sat at lunch ... couldn't help but reflect on how our professional lives continue ... , ,As the CEO of a company that is ... I remain impressed with how quickly technological change continues to ...
    ... a month ago, I wrote a post titled Worst Phone ... general lack of phone-ness on the Cingular 8125. Since that column, ... services have been a little sheepish when they come to tell ... much better grasp of UI than do the well-resourced Cingular ...
    ... - Norlight Telecommunications, Inc., which will spin ... it will roll out its new Voice over Internet ... Green Bay and Madison. , ,The facilities-based communications ... by offering integrated communications bundles of local voice, long ...
    Cached Biology Technology:Visions: Rimas Buinevicius, CEO of Sonic Foundry 2Visions: Rimas Buinevicius, CEO of Sonic Foundry 3More women needed in interface design 2More women needed in interface design 3More women needed in interface design 4Norlight will offer VoIP in Madison, Green Bay 2
    (Date:8/22/2014)... , a leading source of information for businesses and ... California, Riverside in its 2014 list of "some of ... To generate the list, the company analyzed citation data ... work has had enormous impact. , The following UC ... published the greatest number of highly cited papers in ...
    (Date:8/22/2014)... August 21, 2014 Diabetes affects nearly 10 ... complaints of diabetics: constant finger pricking to test ... Chemical Biology reports the development of a protein ... accurate results for diabetes patients. In the American ... Daunert, Ph.D., shows off her "designer protein" that ...
    (Date:8/22/2014)... and clinical research and technological advances, the fight ... spanning multiple fronts. , Work happening in a ... new and more selective therapies for cancer. Researchers ... enzyme overexpressed in certain cancersand they have tested ... Chemistry professor Christopher Cairo and his team synthesized ...
    Breaking Biology News(10 mins):5 UC Riverside scientists among world's most influential scientific minds 2New enzyme targets for selective cancer therapies 2New enzyme targets for selective cancer therapies 3
    ... to wonder how a fruit fly is able to locate ... summer evening, especially since its flight path seems to be ... Andy Reynolds at Rothamsted Research in the United Kingdom have ... their environment using a series of straight flight paths punctuated ...
    ... unique protein from jellyfish that could be inserted into ... them to radiate a brilliant green color. This green ... new discoveries regarding how living cells function. But one ... plants harbor tough cell walls and enormous subcellular ...
    ... the University of East Anglia have discovered exactly what makes ... The age-old mystery was unlocked thanks to some novel bacteria ... Johnston and his team at UEA isolated this microbe from ... single gene responsible for the emission of the strong-smelling gas, ...
    Cached Biology News:Flies don't buzz about aimlessly! 2Cloning the smell of the seaside 2
    Mouse Aminopeptidase P2/XPNPEP2 Biotinylated Aff Pur PAb Keywords: AminopeptidaseP2, Metalloproteinase, Metalloprotease, X-Prolyl Aminopeptidase 2, X-Pro Aminopeptidase 2, Membrane-bound Prote...
    Recommend to use at up to 5000X dilutions for cell culture (e.g. Add 1 ul to 1 ml of culture medium.)...
    Size & Applications: 100 ul (2 mM). Recommend to use at 1000X dilutions for cell culture (e.g. Add 1 ul to 1 ml of culture medium.) Storage Temp.: -20C Shelf Life: 6-12 month...
    in vitro Translation, Accessory Products...
    Biology Products: